Current concepts in age related macular degeneration

1 October 2008
Volume 09, Issue 4

A review of the modern classifications of AMD and available treatments.


Age-related macular degeneration (ARMD) is the commonest cause of visual impairment leading to blind registration among older adults in the western world. Following recently published trials, ophthalmologists around the world now have the knowledge and the drugs to improve visual outcomes and to provide much-needed hope to patients with wet macular degeneration. Further, many research trials are currently under way with more funding to find an even more suitable and effective treatment modality for macular degeneration.

Sign in to continue

Forgotten password?

Sign in to view the article

Not a member? Start enjoying the benefits of College membership today. Take a look at what the College can offer you and view our membership categories and rates.

Related further reading

From refractive error to dashed career opportunities, Kim Thomas discusses the lifelong consequences of amblyopia.

The College is asking for feedback from members on changes to its patient leaflets.

The latest edition of Acuity, the College’s professional journal, is now available in print and online.